PortfoliosLab logoPortfoliosLab logo
Myomo, Inc. (MYO)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US62857J2015
CUSIP
62857J201
IPO Date
Jun 12, 2017

Highlights

Market Cap
$28.28M
Enterprise Value
$22.80M
EPS (TTM)
-$0.37
Total Revenue (TTM)
$40.93M
Gross Profit (TTM)
$26.89M
EBITDA (TTM)
-$12.43M
Year Range
$0.61 - $4.99
Target Price
$5.75
ROA (TTM)
-40.31%
ROE (TTM)
-136.57%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Myomo, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Myomo, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Myomo, Inc. (MYO) has returned -25.76% so far this year and -85.95% over the past 12 months.


Myomo, Inc.

1D
5.55%
1M
-12.83%
YTD
-25.76%
6M
-24.26%
1Y
-85.95%
3Y*
-3.42%
5Y*
-44.83%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 12, 2017, MYO's average daily return is -0.02%, while the average monthly return is -1.62%.

Historically, 36% of months were positive and 64% were negative. The best month was Nov 2023 with a return of +174.3%, while the worst month was Mar 2022 at -48.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, MYO closed higher 44% of trading days. The best single day was Feb 4, 2020 with a return of +114.7%, while the worst single day was Feb 11, 2020 at -45.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-7.79%-7.64%-12.83%-25.76%
2025-6.37%-15.92%-5.13%-2.29%-36.81%-27.27%-10.65%-45.60%-15.05%3.81%-3.89%2.25%-85.87%
2024-33.53%-8.11%6.86%-0.00%4.28%-5.87%48.29%-5.88%-10.49%-8.73%53.55%14.59%28.54%
2023-5.51%34.52%15.38%-21.32%-6.37%-6.17%39.37%6.57%44.16%1.80%174.34%61.61%879.66%
20225.19%3.19%-48.72%-21.78%-24.83%-25.00%0.60%10.06%-12.90%-11.73%-43.17%-37.07%-92.53%
202157.50%5.09%14.90%-23.28%8.25%1.60%-30.28%42.90%10.50%-14.80%-19.25%-16.32%1.71%

Benchmark Metrics

Myomo, Inc. has an annualized alpha of -16.32%, beta of 1.01, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since June 13, 2017.

  • This stock participated in 115.69% of S&P 500 Index downside but only -94.27% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-16.32%
Beta
1.01
0.03
Upside Capture
-94.27%
Downside Capture
115.69%

Return for Risk

Risk / Return Rank

MYO ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


MYO Risk / Return Rank: 55
Overall Rank
MYO Sharpe Ratio Rank: 44
Sharpe Ratio Rank
MYO Sortino Ratio Rank: 11
Sortino Ratio Rank
MYO Omega Ratio Rank: 22
Omega Ratio Rank
MYO Calmar Ratio Rank: 22
Calmar Ratio Rank
MYO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Myomo, Inc. (MYO) and compare them to a chosen benchmark (S&P 500 Index).


MYOBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.99

0.90

-1.88

Sortino ratio

Return per unit of downside risk

-2.15

1.39

-3.54

Omega ratio

Gain probability vs. loss probability

0.72

1.21

-0.49

Calmar ratio

Return relative to maximum drawdown

-0.99

1.40

-2.39

Martin ratio

Return relative to average drawdown

-1.24

6.61

-7.84

Explore MYO risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Myomo, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Myomo, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Myomo, Inc. was 99.93%, occurring on Jan 12, 2023. The portfolio has not yet recovered.

The current Myomo, Inc. drawdown is 99.88%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.93%Jun 20, 20171402Jan 12, 2023
-8.56%Jun 13, 20172Jun 14, 20171Jun 15, 20173

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Myomo, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Myomo, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MYO relative to other companies in the Medical Devices industry. Currently, MYO has a P/S ratio of 0.7. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for MYO in comparison with other companies in the Medical Devices industry. Currently, MYO has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items